(Q42502216)

English

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Fasciola hepatica

object named as

Fasciola hepatica

1 reference

based on heuristic

inferred from title

author name string

M McConville

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

G P Brennan

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

M McCoy

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

R Castillo

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

A Hernandez-Campos

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

F Ibarra

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

I Fairweather

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

3 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

365-377

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

https://scigraph.springernature.com/pub.10.1007/s00436-006-0270-4

0 references

Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica

1 reference

https://api.crossref.org/works/10.1007%2FS00436-006-0270-4

21 January 2018

Tegumental surface changes in adult Fasciola hepatica following treatment in vitro and in vivo with an experimental fasciolicide

1 reference

https://api.crossref.org/works/10.1007%2FS00436-006-0270-4

21 January 2018

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-006-0270-4

21 January 2018

Triclabendazole-resistant Fasciola hepatica in southwest Wales.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Praziquantel-induced vesicle formation in the tegument of male Schistosoma mansoni is calcium dependent

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between tegumental disruption and muscle contraction in Schistosoma mansoni exposed to various compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the effective dose of an experimental fasciolicide in naturally and experimentally infected cattle

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen').

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the 5-chloro-2-methylthio-6-(1-naphtyloxy)-1H-benzimidazole on the tegument of immature Fasciola hepatica in their natural host

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of closantel against adult triclabendazole-resistant Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of Fasciola hepatica to triclabendazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Field trial on the efficacy of an experimental fasciolicide compared with some commercial compounds in naturally infected cattle

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic assay for a new fasciolicide agent, alphaBIOF10, in biological fluids

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17016729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-006-0270-4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42502216&oldid=1959950636"